Brach Eichler Represents Bucks-Mont Eye Associates in its M&A Transaction with Vision Innovation Partners (VIP)

BACK TO INSIGHTS     Firm Announcements & Wins


Vice Chair of Brach Eichler’s Healthcare Law Practice, Isabelle Bibet-Kalinyak, Esq. represented Bucks-Mont Eye Associates in its M& A transaction with private equity-backed Vision Innovation Partners (VIP) which closed just before the new year rang. Isabelle’s experience in healthcare law, mergers and acquisitions and vision care was vital in navigating this complex transaction, showcasing her legal acumen in the healthcare industry.

This acquisition not only marks a significant expansion for VIP but also highlights the essential role of legal and financial guidance in successful healthcare mergers.

Bucks-Mont, celebrating its 50th anniversary, is known for its expert team of eye care professionals. It was guided in this transaction by Christopher Gammill from Cross Keys Capital, an investment banking firm with a proven track record in vision care. VIP, headquartered in Annapolis, Maryland, operates nearly 70 locations, emphasizing a collaborative approach to managing ophthalmology practices.

Behind this acquisition is Gryphon Investors, a private equity firm with a focus on healthcare, holding about $9 billion in assets. Their investment strategy targets companies with significant EBITDA, making them a perfect backer for VIP’s expansion goals.

For more information and to contact Isabelle, visit

*Results may vary depending on your particular facts and legal circumstances.

Related Practices:   Healthcare Law

Related Attorney:   Isabelle Bibet-Kalinyak

Related Industry:   Healthcare